This inventor holds 1 USPTO granted patent. Top assignee: Navitor Pharmaceuticals, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Steven Leventer: Innovator in mTORC1 Modulation
Introduction
Steven Leventer is a notable inventor based in Cambridge, MA, who has made significant contributions to the field of biotechnology. He is particularly recognized for his work on methods of treatment using an mTORC1 modulator. His innovative approach has the potential to impact various therapeutic areas.
Latest Patents
Leventer holds a patent for "Methods of treatment using an mTORC1 modulator." This invention relates to methods, compositions, and unit dosage forms that are useful for selectively modulating mTORC1 activity. The patent highlights the importance of mTORC1 in cellular processes and its implications for treatment strategies.
Career Highlights
Steven Leventer is currently associated with Navitor Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work at Navitor focuses on leveraging mTORC1 modulation to create effective therapeutic solutions.
Collaborations
Leventer collaborates with Steven D. Targum, enhancing the research and development capabilities within his team. Their combined expertise contributes to the innovative environment at Navitor Pharmaceuticals.
Conclusion
Steven Leventer is a prominent figure in the field of biotechnology, with a focus on mTORC1 modulation. His contributions through patents and collaboration are paving the way for advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile